felbamate has been researched along with Intellectual Disability in 4 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our patient's electrographic status epilepticus of sleep resolved after treatment with felbamate." | 7.81 | Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation. ( Coorg, R; Weisenberg, JL, 2015) |
| "Our patient's electrographic status epilepticus of sleep resolved after treatment with felbamate." | 3.81 | Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation. ( Coorg, R; Weisenberg, JL, 2015) |
| "Felbamate was launched in 1993 in the U." | 2.40 | Felbamate: clinical and molecular aspects of a unique antiepileptic drug. ( Aiken, SP; Brown, WM, 1998) |
| "Epilepsy is common in individuals who are mentally retarded and/or otherwise multiply handicapped." | 2.39 | The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps. ( Mattson, RH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coorg, R | 1 |
| Weisenberg, JL | 1 |
| Mattson, RH | 1 |
| Sunder, TR | 1 |
| Brown, WM | 1 |
| Aiken, SP | 1 |
3 reviews available for felbamate and Intellectual Disability
| Article | Year |
|---|---|
The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.
Topics: Acetates; Amines; Anticonvulsants; Cerebral Palsy; Cyclohexanecarboxylic Acids; Disabled Persons; Dr | 1996 |
Meeting the challenge of epilepsy in persons with multiple handicaps.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Comorbidity; Developmental Disabilities | 1997 |
Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Drug Resistance; Epilepsy; Felbamate; Humans; In | 1998 |
1 other study available for felbamate and Intellectual Disability
| Article | Year |
|---|---|
Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation.
Topics: Anticonvulsants; Ataxia; Child; Epilepsy; Felbamate; Genetic Diseases, X-Linked; Humans; Intellectua | 2015 |